Obagi Medical Products, Inc. (OMPI) appointed Mark T. Taylor as senior vice president, corporate development and investor relations. He comes to Obagi with more than 20 years of experience working with specialty pharmaceutical companies in high-level capacities. Most recently, Taylor was at Roth Capital Partners, LLC where for over a six-year tenure he served health care clients in institutional sales, investment banking, and equity research. From May of 2003 to October of 2007, he was Roth’...